Andreas Jungmann

2.1k total citations
33 papers, 959 citations indexed

About

Andreas Jungmann is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Andreas Jungmann has authored 33 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Cardiology and Cardiovascular Medicine and 12 papers in Genetics. Recurrent topics in Andreas Jungmann's work include Virus-based gene therapy research (9 papers), Signaling Pathways in Disease (9 papers) and Viral Infections and Immunology Research (8 papers). Andreas Jungmann is often cited by papers focused on Virus-based gene therapy research (9 papers), Signaling Pathways in Disease (9 papers) and Viral Infections and Immunology Research (8 papers). Andreas Jungmann collaborates with scholars based in Germany, United States and United Kingdom. Andreas Jungmann's co-authors include Oliver J. Müller, Hugo A. Katus, Barbara Leuchs, Felix Lasitschka, Lorenz Lehmann, Ziya Kaya, Johannes Backs, Roland Vetter, Henry Fechner and Wolfgang Poller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Andreas Jungmann

33 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Jungmann Germany	15	565	323	164	93	91	33	959
Kathryn C. Chatfield United States	16	583 1.0×	131 0.4×	108 0.7×	89 1.0×	37 0.4×	48	802
Béatrice Jaspard‐Vinassa France	24	631 1.1×	198 0.6×	89 0.5×	103 1.1×	135 1.5×	35	1.3k
Mónica Zamora Spain	15	789 1.4×	184 0.6×	61 0.4×	130 1.4×	122 1.3×	26	1.1k
Delphine Courilleau France	15	788 1.4×	83 0.3×	204 1.2×	87 0.9×	97 1.1×	19	1.1k
Haocheng Lu United States	17	514 0.9×	126 0.4×	98 0.6×	92 1.0×	114 1.3×	39	1.1k
Audrey Noguchi United States	14	399 0.7×	105 0.3×	61 0.4×	283 3.0×	95 1.0×	26	950
Senad Medunjanin Germany	14	675 1.2×	89 0.3×	163 1.0×	51 0.5×	195 2.1×	18	1.0k
Rosanna C. Mirabile United States	13	580 1.0×	298 0.9×	45 0.3×	155 1.7×	148 1.6×	20	1.1k
Patrick S. Lin United States	13	442 0.8×	256 0.8×	53 0.3×	291 3.1×	64 0.7×	23	1.0k
John W. Adams United States	17	958 1.7×	437 1.4×	72 0.4×	123 1.3×	49 0.5×	22	1.3k

Countries citing papers authored by Andreas Jungmann

Since Specialization

Citations

This map shows the geographic impact of Andreas Jungmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Jungmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Jungmann more than expected).

Fields of papers citing papers by Andreas Jungmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Jungmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Jungmann. The network helps show where Andreas Jungmann may publish in the future.

Co-authorship network of co-authors of Andreas Jungmann

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Jungmann. A scholar is included among the top collaborators of Andreas Jungmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Jungmann. Andreas Jungmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salatzki, Janek, Erhe Gao, Walter J. Koch, et al.. (2025). Cardiac-Targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts. Circulation Heart Failure. 18(7). e012479–e012479. 2 indexed citations

Seitz, Andreas, Martin Busch, Stéphanie Simon, et al.. (2024). S100A1’s single cysteine is an indispensable redox switch for the protection against diastolic calcium waves in cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 327(1). H275–H286. 3 indexed citations

Jungmann, Andreas, Staffan Hildebrand, Martin Busch, et al.. (2021). Development of an AAV9-RNAi-mediated silencing strategy to abrogate TRPM4 expression in the adult heart. Pflügers Archiv - European Journal of Physiology. 473(3). 533–546. 4 indexed citations

Li, Xue, Andreas Jungmann, Johannes Backs, et al.. (2020). Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction. Circulation. 141(20). 1628–1644. 54 indexed citations

Yap, Yann Wan, Patricia M. Rusu, Andrea Y. Chan, et al.. (2020). Restriction of essential amino acids dictates the systemic metabolic response to dietary protein dilution. Nature Communications. 11(1). 2894–2894. 78 indexed citations

Heckmann, Markus, Kleopatra Rapti, Dorothea Schultheis, et al.. (2020). AAV-mediated cardiac gene transfer of wild-type desmin in mouse models for recessive desminopathies. Gene Therapy. 27(10-11). 516–524. 9 indexed citations

Remes, Anca, Maximilian Franz, F. Mohr, et al.. (2019). AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic Allografts. Molecular Therapy — Methods & Clinical Development. 15. 246–256. 7 indexed citations

Bauer, Ralf, Andreas Jungmann, Barbara Leuchs, et al.. (2018). Various effects of AAV9-mediated βARKct gene therapy on the heart in dystrophin-deficient (mdx) mice and δ-sarcoglycan-deficient (Sgcd-/-) mice. Neuromuscular Disorders. 29(3). 231–241. 10 indexed citations

Tilemann, Lisa, Ralf Bauer, Markus Heckmann, et al.. (2018). AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload. Gene Therapy. 25(1). 13–19. 10 indexed citations

10.

Jungmann, Andreas, Christoph Dieterich, Min Zhang, et al.. (2017). The cardiac microenvironment uses non‐canonical WNT signaling to activate monocytes after myocardial infarction. EMBO Molecular Medicine. 9(9). 1279–1293. 55 indexed citations

11.

Liu, Wei, Andrea Ruiz‐Velasco, Shoubao Wang, et al.. (2017). Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling. Nature Communications. 8(1). 494–494. 66 indexed citations

12.

Jungmann, Andreas, Barbara Leuchs, Hugo A. Katus, Jean Rommelaere, & Oliver J. Müller. (2017). Protocol for efficient generation and characterization of adeno-associated viral (AAV) vectors. Human Gene Therapy Methods. 5 indexed citations

13.

Jungmann, Andreas, Barbara Leuchs, Jean Rommelaere, Hugo A. Katus, & Oliver J. Müller. (2017). Protocol for Efficient Generation and Characterization of Adeno-Associated Viral Vectors. Human Gene Therapy Methods. 28(5). 235–246. 46 indexed citations

14.

Jungmann, Andreas, Oliver J. Müller, & Kleopatra Rapti. (2016). Cell-Based Measurement of Neutralizing Antibodies Against Adeno-Associated Virus (AAV). Methods in molecular biology. 1521. 109–126. 14 indexed citations

15.

Heckmann, Markus, Ralf Bauer, Andreas Jungmann, et al.. (2016). AAV9-mediated gene transfer of desmin ameliorates cardiomyopathy in desmin-deficient mice. Gene Therapy. 23(8-9). 673–679. 10 indexed citations

16.

Voelkl, Jakob, Ioana Alesutan, Uwe Primeßnig, et al.. (2016). AMP-activated protein kinase α1-sensitive activation of AP-1 in cardiomyocytes. Journal of Molecular and Cellular Cardiology. 97. 36–43. 14 indexed citations

17.

Kreußer, Michael M., Lorenz Lehmann, Stanislav Keranov, et al.. (2016). Inducible cardiomyocyte-specific deletion of CaM kinase II protects from pressure overload-induced heart failure. Basic Research in Cardiology. 111(6). 65–65. 38 indexed citations

18.

Neacșu, Ionela Andreea, Sven W. Sauer, Philip Raake, et al.. (2013). Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model. Gene Therapy. 21(2). 131–138. 31 indexed citations

19.

Geisler, Anja, Andreas Jungmann, Jens Kurreck, et al.. (2010). microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Therapy. 18(2). 199–209. 105 indexed citations

20.

Jungmann, Andreas & Ralf R. Tönjes. (2008). Retrotransposition: Another Obstacle for Xenotransplantation?. Transplantation Proceedings. 40(2). 596–597. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact